Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02694822 |
|---|---|
| Brief Title: | AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Subjects With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy |
| First Submitted : | February 12, 2016 |
| First Submitted that Met QC Criteria : | February 24, 2016 |
| First Posted : | March 1, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 28, 2022 |
| Last Update Posted : | April 29, 2022 |